Ephla Bio is building the future of personalized medicine by enabling therapies that target the 80% of disease-driving proteins hidden inside cells—targets conventional biologics can’t reach
Ephla Bio is building the future of personalized medicine by enabling therapies that target the 80% of disease-driving proteins hidden inside cells—targets conventional biologics can’t reach. Our AI-driven platform predicts patient-specific intracellular targets, unlocking personalized and semi-personalized therapeutics for diseases that currently lack treatment options.